SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi Consumer Healthcare India board to consider dividend

04 Mar 2025 Evaluate
Further to letter dated 20th February 2025, in reference to outcome of the Board Meeting held on 20th February, 2025 where the Board recommended a final dividend of Rs 55 per equity share of the face value of Rs 10 each, subject to the approval of Shareholders at the ensuing 2nd Annual General Meeting, Sanofi Consumer Healthcare India has informed that the Register of Member and Share Transfer Books of the Company will remain closed from Tuesday, 29th April 2025 to Monday, 5th May 2025 for the purpose of payment of Final Dividend for the year ended 31st December 2024 (Final Dividend). Accordingly, the record date for the payment, shall be Monday, 28th April 2025.

The above information is a part of company’s filings submitted to BSE.

Sanofi Cons. Health Share Price

4722.55 1.05 (0.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×